Sanofi registers Phase 2b hidradenitis suppurativa trial; RSV+HMPV vaccine study recruitingSep 10Weekly roundup, 2 itemsduvakitugSanofi
Teva posts Q2 2026 GAAP loss on Emalex charge, raises innovative brand outlookJul 29Quarterly updatedeutetrabenazinefremanezumab-vfrm
Sign inSign in